Biotricity, Inc. (BTCY)

Market Cap	17.72M
Revenue (ttm)	10.60M
Net Income (ttm)	-18.11M
Shares Out	8.32M
EPS (ttm)	-2.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,284
Open	2.08
Previous Close	2.14
Day's Range	2.08 - 2.16
52-Week Range	0.40 - 3.78
Beta	2.35
Analysts	Strong Buy
Price Target	4.00 (+87.79%)
Earnings Date	Nov 13, 2023

About BTCY

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, Cali...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Dr. Waqaas Al-Siddiq Ph.D.
• Employees: 55
• Stock Exchange: NASDAQ
• Ticker Symbol: BTCY

Financial Performance

In 2022, Biotricity's revenue was $9.64 million, an increase of 26.00% compared to the previous year's $7.65 million. Losses were -$19.53 million, -35.36% less than in 2021.

Analyst Forecast

According to one analyst, the rating for BTCY stock is "Strong Buy" and the 12-month stock price forecast is $4.0.

Price Target

$4.0

(87.79% upside)

Analyst Consensus: Strong Buy